A

Alta Pharmaceutical Research Center | Dunwoody, GA

Research site
(Unclaimed)
Location
4553 North Shallowford Road Suite 50B, Dunwoody, Georgia, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 11
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease (PREVAIL)

This study will be a placebo-controlled, double-blind, randomized, phase 3 study in participants with Atherosclerotic Cardiovascular Disease (ASCVD)...

Enrolling
Atherosclerotic Cardiovascular Disease
Drug: Placebo
Drug: Obicetrapib

This study will be a placebo-controlled, double-blind, randomized, phase 3 study in participants with underlying heterozygous familial hypercholester...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Dyslipidemias
Drug: Obicetrapib
Drug: Placebo

This is an open-label extension of the parent studies AROAPOC3-2001 and AROAPOC3-2002. Adult participants with dyslipidemia who completed the blinded...

Active, not recruiting
Dyslipidemias
Drug: ARO-APOC3

Trial conditions

Cardiovascular Diseases (4 trials)
Dyslipidemias (3 trials)
Atherosclerosis (2 trials)
Type 2 Diabetes Mellitus (2 trials)
Arthritis (1 trial)
Atrial Fibrillation (1 trial)
Diabetes Mellitus (1 trial)
Embolism (1 trial)
Gouty Arthritis (1 trial)
Hypercholesterolemia (1 trial)

And 4 more

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems